Emisphere Technologies, Inc. (OTCMKTS:EMIS)’s stock price was down 1.6% during trading on Friday . The stock traded as low as $9.39 and last traded at $9.38, approximately 16,325 shares changed hands during mid-day trading. A decline of 66% from the average daily volume of 47,876 shares. The stock had previously closed at $9.53.
The firm has a 50-day simple moving average of $9.86 and a 200 day simple moving average of $8.23.
About Emisphere Technologies (OTCMKTS:EMIS)
Emisphere Technologies, Inc operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions.
See Also: Overbought
Receive News & Ratings for Emisphere Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emisphere Technologies and related companies with MarketBeat.com's FREE daily email newsletter.